Presentation Information

[28-19-pm15S]Population Pharmacokinetic-Pharmacodynamic Analysis of Triglyceride-Lowering Effects of Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin

○Ryosuke Terada1, Shinji Kobuchi1, Yukako Ito1, Kenichiro Kato2, Tetsuo Hayakawa2, Toshiyuki Sakaeda1 (1. Kyoto Pharm. Univ., 2. Tonami General Hosp. Diabetes/Endocrinology)